510(k) Report

510(k) · Cleared

Cleared

Amd 6605 Tens/Nmes

K092990510(k) TraditionalCleared Oct 23, 200925-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Advantageous Medical Devices, LLC · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

Cleared on Oct 23, 2009 as substantially equivalent to K032954 (Danmeter A/S, 2004) after a 25-day review. Its family tree reaches back 1 generation to 2004. 2 later devices descend from it.

Decided
Oct 23, 2009
Review
25 days
Class
Class II
Product code
GZJ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K032954 (2004). 2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2016: 1 descendant cleared2017: 1 descendant clearedK032954 · Elpha, Models II 500, II 1000, II 2000, II 3000 and E80 · Danmeter A/S · 2004200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant K032954 · Elpha, Models II 500, II 1000, II 2000, II 3000 and E80 · Danmeter A/S · 20040
  1. Root · 1 generation backK032954 Elpha, Models II 500, II 1000, II 2000, II 3000 and E80Danmeter A/S · 2004
  2. This deviceK092990 Amd 6605 Tens/NmesAdvantageous Medical Devices, LLC · 2009
  3. Descendant · cites it directly · 1 of its ownK151922 StimSox (TM) SystemStimmed, LLC · 2016
  4. Descendant · 2 generations on · 0 of its ownK171071 StimSox (TM) SystemStimmed, LLC · 2017

Most influential descendants

Showing 2 of 2 · See all
  • K151922StimSox (TM) SystemStimmed, LLC · 2016 · cites it directly1descendant
  • K171071StimSox (TM) SystemStimmed, LLC · 2017 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K032954Elpha, Models II 500, II 1000, II 2000, II 3000 and E80Danmeter A/S2004—
0 (this device)K092990Amd 6605 Tens/NmesAdvantageous Medical Devices, LLC2009—
+1K151922StimSox (TM) SystemStimmed, LLC2016—
+2K171071StimSox (TM) SystemStimmed, LLC2017—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
201710
FIG. 1 — Lineage of K092990, 2004–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZJ device

  1. #1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032954Elpha, Models II 500, II 1000, II 2000, II 3000 and E80
Summary page 2
…age 2 === Predicate Device Identification: 21CFR:890.5850 Product Code: IPFIGZJ Device Class: II Legally Marketed Device: Elpha 11 3000 Manufacturer: Danmeter A/S K#: K032954 Device Description: AMD 6605 TENS portion: is designed to provide electrical stimulation, for the following: · Symptomatic re…
Danmeter A/S2004—

Also cleared against K032954: 2 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K151922StimSox (TM) SystemStimmed, LLC20161

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K151922 (Stimmed, LLC, 2016) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K032954.

How does its category compare?

All GZJ devices

GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · GZJ

1in 2025

2007: 132008: 112009: 162010: 52011: 52012: 122013: 22014: 42015: 32016: 32017: 32018: 22019: 32020: 42021: 32022: 42023: 12024: 32025: 12026 (partial year): 2
2007high 16 (2009) · low 1 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZJ

207in 2024

2007: 223 days median2008: 136 days median2009: 155 days median2010: 232 days median2011: 168 days median2012: 154 days median2014: 344 days median2015: 202 days median2016: 163 days median2017: 113 days median2019: 156 days median2020: 183 days median2021: 231 days median2022: 175 days median2024: 207 days median
2007high 344 (2014) · low 113 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZJ

1in 2011

2007: 42008: 12011: 1
2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZJ

13in 2025

2007: 42008: 452009: 172010: 222011: 222012: 202013: 102014: 232015: 182016: 322017: 582018: 212019: 72020: 102021: 52022: 42023: 392024: 122025: 13
2007high 58 (2017) · low 4 (2007)2025

MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071322344
200811136145
200916155017
20105232022
20115168122
201212154020
20132—010
20144344023
20153202018
20163163032
20173113058
20182—021
2019315607
20204183010
2021323105
2022417504
20231—039
20243207012
20251—013
20262—0—

What is it indicated for?

Symptomatic relief and management of chronic (long-term), intractable pain and an adjunctive treatment in the management of post-surgical pain and post-traumatic acute pain

Relaxation of muscle spasms

Prevention or retardation of disuse atrophy

Increasing local blood circulation

Muscle re-education

Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis

Maintaining or increasing range of motion

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092990: Amd 6605 Tens/Nmes.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K092990

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026